 MOUNTAIN VIEW, Calif., May 13, 2022 GLOBE NEWSWIRE -- NeuroPace, Inc. Nasdaq: NPCE, a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today announced it will be participating in the upcoming 2022 RBC Capital Markets Global Healthcare Conference. Mike Favet, CEO, is scheduled to present on Tuesday, May 17 at 9:30 a.m. Eastern Time. A live webcast of this event, as well as an archived recording, will be available on the Investors section of the companys website at: The webcasts will be archived and available for replay for at least 90 days after the event. 